Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Unintended pregnancy rates differ according to combined oral contraceptive - results from the INAS-SCORE study.

Barnett C, Dinger J, Minh TD, Heinemann K.

Eur J Contracept Reprod Health Care. 2019 Aug;24(4):247-250. doi: 10.1080/13625187.2019.1629412. Epub 2019 Jun 17.

PMID:
31204884
2.

Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA).

Reed S, Do Minh T, Lange JA, Koro C, Fox M, Heinemann K.

Contraception. 2019 Jul;100(1):31-36. doi: 10.1016/j.contraception.2019.03.052. Epub 2019 Apr 10.

PMID:
30980829
3.

Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study.

Barnett C, Moehner S, Do Minh T, Heinemann K.

Eur J Contracept Reprod Health Care. 2017 Dec;22(6):424-428. doi: 10.1080/13625187.2017.1412427. Epub 2018 Jan 11.

PMID:
29322856
4.

Participatory action research opens doors: Mentoring Indigenous researchers to improve midwifery in urban Australia.

Hickey SD, Maidment SJ, Heinemann KM, Roe YL, Kildea SV.

Women Birth. 2018 Aug;31(4):263-268. doi: 10.1016/j.wombi.2017.10.011. Epub 2017 Nov 8.

PMID:
29128437
5.

Protoplast Swelling and Hypocotyl Growth Depend on Different Auxin Signaling Pathways.

Dahlke RI, Fraas S, Ullrich KK, Heinemann K, Romeiks M, Rickmeyer T, Klebe G, Palme K, Lüthen H, Steffens B.

Plant Physiol. 2017 Oct;175(2):982-994. doi: 10.1104/pp.17.00733. Epub 2017 Aug 31.

6.

Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.

Murray MJ, Bailey S, Heinemann K, Mann J, Göbel UK, Saran F, Hale JP, Calaminus G, Nicholson JC.

Int J Cancer. 2017 Aug 1;141(3):621-635. doi: 10.1002/ijc.30755. Epub 2017 May 15.

7.

IUD use among parous women and risk of uterine perforation: a secondary analysis.

Heinemann K, Barnett C, Reed S, Möhner S, Do Minh T.

Contraception. 2017 Jun;95(6):605-607. doi: 10.1016/j.contraception.2017.03.007. Epub 2017 Mar 16.

PMID:
28322770
8.

Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study.

Barnett C, Hagemann C, Dinger J, Do Minh T, Heinemann K.

Eur J Contracept Reprod Health Care. 2017 Feb;22(1):17-23. doi: 10.1080/13625187.2016.1241991. Epub 2016 Oct 17.

PMID:
27749101
9.

Impact of estrogen type on cardiovascular safety of combined oral contraceptives.

Dinger J, Do Minh T, Heinemann K.

Contraception. 2016 Oct;94(4):328-39. doi: 10.1016/j.contraception.2016.06.010. Epub 2016 Jun 22.

PMID:
27343748
10.

Drospirenone plus estradiol and the risk of serious cardiovascular events in postmenopausal women.

Dinger J, Bardenheuer K, Heinemann K.

Climacteric. 2016 Aug;19(4):349-56. doi: 10.1080/13697137.2016.1183624. Epub 2016 May 13.

PMID:
27174159
11.

Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients.

Heinemann K, Wilde B, Hoerning A, Tebbe B, Kribben A, Witzke O, Dolff S.

Scand J Rheumatol. 2016 Jul;45(4):312-6. doi: 10.3109/03009742.2015.1126346. Epub 2016 Mar 7.

PMID:
26948375
12.

Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives.

Dinger J, Möhner S, Heinemann K.

Contraception. 2016 May;93(5):378-85. doi: 10.1016/j.contraception.2016.01.012. Epub 2016 Jan 26.

PMID:
26825258
13.

Cerebral Palsy: A Lifelong Challenge Asks for Early Intervention.

Panteliadis CP, Hagel C, Karch D, Heinemann K.

Open Neurol J. 2015 Jun 26;9:45-52. doi: 10.2174/1874205X01509010045. eCollection 2015.

14.

Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.

Heinemann K, Reed S, Moehner S, Minh TD.

Contraception. 2015 Apr;91(4):274-9. doi: 10.1016/j.contraception.2015.01.007. Epub 2015 Jan 16.

15.

Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.

Heinemann K, Reed S, Moehner S, Minh TD.

Contraception. 2015 Apr;91(4):280-3. doi: 10.1016/j.contraception.2015.01.011. Epub 2015 Jan 16.

16.
17.

Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring.

Dinger J, Möhner S, Heinemann K.

Obstet Gynecol. 2013 Oct;122(4):800-8. doi: 10.1097/AOG.0b013e3182a5ec6b.

PMID:
24084537
18.

COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells.

Ramer R, Heinemann K, Merkord J, Rohde H, Salamon A, Linnebacher M, Hinz B.

Mol Cancer Ther. 2013 Jan;12(1):69-82. doi: 10.1158/1535-7163.MCT-12-0335. Epub 2012 Dec 7.

19.

Epidemiology of premenstrual symptoms and disorders.

Dennerstein L, Lehert P, Heinemann K.

Menopause Int. 2012 Jun;18(2):48-51. doi: 10.1258/mi.2012.012013. Review.

PMID:
22611221
20.

Intercountry assessment of the impact of severe premenstrual disorders on work and daily activities.

Heinemann LA, Minh TD, Heinemann K, Lindemann M, Filonenko A.

Health Care Women Int. 2012;33(2):109-24. doi: 10.1080/07399332.2011.610530.

PMID:
22242652
21.

Global epidemiological study of variation of premenstrual symptoms with age and sociodemographic factors.

Dennerstein L, Lehert P, Heinemann K.

Menopause Int. 2011 Sep;17(3):96-101. doi: 10.1258/mi.2011.011028.

PMID:
21903713
22.

Global study of women's experiences of premenstrual symptoms and their effects on daily life.

Dennerstein L, Lehert P, Heinemann K.

Menopause Int. 2011 Sep;17(3):88-95. doi: 10.1258/mi.2011.011027.

PMID:
21903712
23.

Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.

Heinemann K, Heinemann LA.

J Fam Plann Reprod Health Care. 2011 Jul;37(3):132-5. doi: 10.1136/jfprhc-2011-14524. Epub 2011 Jun 9. No abstract available.

24.

Ethinyl estradiol 20μg/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder.

Marr J, Heinemann K, Kunz M, Rapkin A.

Int J Gynaecol Obstet. 2011 May;113(2):103-7. doi: 10.1016/j.ijgo.2010.10.029. Epub 2011 Feb 19.

PMID:
21338987
25.

Ethylene-regulated (methylsulfanyl)alkanoate ester biosynthesis is likely to be modulated by precursor availability in Actinidia chinensis genotypes.

Günther CS, Heinemann K, Laing WA, Nicolau L, Marsh KB.

J Plant Physiol. 2011 May 1;168(7):629-38. doi: 10.1016/j.jplph.2010.10.001. Epub 2010 Nov 10.

PMID:
21071110
26.

Premenstrual symptoms -- severity, duration and typology: an international cross-sectional study.

Dennerstein L, Lehert P, Bäckström TC, Heinemann K.

Menopause Int. 2009 Sep;15(3):120-6. doi: 10.1258/mi.2009.009030.

PMID:
19723682
27.

Interspecies signaling between Veillonella atypica and Streptococcus gordonii requires the transcription factor CcpA.

Johnson BP, Jensen BJ, Ransom EM, Heinemann KA, Vannatta KM, Egland KA, Egland PG.

J Bacteriol. 2009 Sep;191(17):5563-5. doi: 10.1128/JB.01226-08. Epub 2009 Jun 19.

28.

The effect of premenstrual symptoms on activities of daily life.

Dennerstein L, Lehert P, Bäckström TC, Heinemann K.

Fertil Steril. 2010 Aug;94(3):1059-64. doi: 10.1016/j.fertnstert.2009.04.023. Epub 2009 May 31.

PMID:
19486964
29.

Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.

Heinemann K, Rübig A, Strothmann A, Nahum GG, Heinemann LA.

J Womens Health (Larchmt). 2008 Sep;17(7):1151-66. doi: 10.1089/jwh.2007.0584.

PMID:
18774896
30.

Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation.

von Köckritz-Blickwede M, Goldmann O, Thulin P, Heinemann K, Norrby-Teglund A, Rohde M, Medina E.

Blood. 2008 Mar 15;111(6):3070-80. doi: 10.1182/blood-2007-07-104018. Epub 2008 Jan 8.

PMID:
18182576
31.

The compactEASIE is a feasible training model for endoscopic novices: a prospective randomised trial.

Maiss J, Millermann L, Heinemann K, Naegel A, Peters A, Matthes K, Hahn EG, Hochberger J.

Dig Liver Dis. 2007 Jan;39(1):70-8; discussion 79-80. Epub 2006 Aug 30.

PMID:
16942923
32.

Docosahexaenoic acid accumulates in plasma of canine puppies raised on alpha-linolenic acid-rich milk during suckling but not when fed alpha-linolenic acid-rich diets after weaning.

Bauer JE, Heinemann KM, Lees GE, Waldron MK.

J Nutr. 2006 Jul;136(7 Suppl):2087S-2089S. doi: 10.1093/jn/136.7.2087S. No abstract available.

PMID:
16772507
33.

Retinal functions of young dogs are improved and maternal plasma phospholipids are altered with diets containing long-chain n-3 polyunsaturated fatty acids during gestation, lactation, and after weaning.

Bauer JE, Heinemann KM, Lees GE, Waldron MK.

J Nutr. 2006 Jul;136(7 Suppl):1991S-1994S. doi: 10.1093/jn/136.7.1991S. No abstract available.

PMID:
16772476
34.

Docosahexaenoic acid and neurologic development in animals.

Heinemann KM, Bauer JE.

J Am Vet Med Assoc. 2006 Mar 1;228(5):700-5, 655. Review.

PMID:
16506930
35.

Scale for Quality of Sexual Function (QSF) as an outcome measure for both genders?

Heinemann LA, Potthoff P, Heinemann K, Pauls A, Ahlers CJ, Saad F.

J Sex Med. 2005 Jan;2(1):82-95.

PMID:
16422910
37.

Expectations toward a novel male fertility control method and potential user types: results of a multinational survey.

Heinemann K, Saad F, Wiesemes M, Heinemann LA.

J Androl. 2005 Mar-Apr;26(2):155-62. No abstract available.

PMID:
15713817
38.

Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency?

Heinemann LA, Saad F, Heinemann K, Thai DM.

Aging Male. 2004 Sep;7(3):211-8.

PMID:
15669540
39.

Attitudes toward male fertility control: results of a multinational survey on four continents.

Heinemann K, Saad F, Wiesemes M, White S, Heinemann L.

Hum Reprod. 2005 Feb;20(2):549-56. Epub 2004 Dec 17.

PMID:
15608042
40.

Multicystic peritoneal mesothelioma of the omentum.

Horn LC, Schütz A, Heinemann K, Einenkel J, Schneider JP.

Eur J Obstet Gynecol Reprod Biol. 2004 Oct 15;116(2):246-7. No abstract available.

PMID:
15358480
41.

The Menopause Rating Scale (MRS) scale: a methodological review.

Heinemann K, Ruebig A, Potthoff P, Schneider HP, Strelow F, Heinemann LA, Do MT.

Health Qual Life Outcomes. 2004 Sep 2;2:45.

42.

Maternal diet alpha-linolenic acid during gestation and lactation does not increase docosahexaenoic acid in canine milk.

Bauer JE, Heinemann KM, Bigley KE, Lees GE, Waldron MK.

J Nutr. 2004 Aug;134(8 Suppl):2035S-2038S. doi: 10.1093/jn/134.8.2035S. No abstract available.

PMID:
15284396
43.

Sweating attacks: key symptom in menopausal transition only for women?

Heinemann K, Saad F.

Eur Urol. 2003 Nov;44(5):583-7.

PMID:
14572758
44.

Liver transplantation for hepatic and neurological Wilson's disease.

Geissler I, Heinemann K, Rohm S, Hauss J, Lamesch P.

Transplant Proc. 2003 Jun;35(4):1445-6.

PMID:
12826186
45.

Benign gynecological tumors: estimated incidence. Results of the German Cohort Study on Women's Health.

Heinemann K, Thiel C, Möhner S, Lewis MA, Raff T, Kühl-Habich D, Heinemann LA; German Cohort Study on Women's Health.

Eur J Obstet Gynecol Reprod Biol. 2003 Mar 26;107(1):78-80.

PMID:
12593900
46.

[Reliability of the Menopause Rating Scale (MRS): Investigation in the German population].

Heinemann K, Assmann A, Möhner S, Schneider HP, Heinemann LA.

Zentralbl Gynakol. 2002 Mar;124(3):161-3. German.

PMID:
12070795
47.

[Trends of OC use 1980-1999 in a German cohort of women].

Heinemann K, Moehner S, Lewis M, Assmann A, Garbe E, Heinemann LA.

Zentralbl Gynakol. 2002 Feb;124(2):128-31. German.

PMID:
11935500
48.

Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results.

Pridöhl O, Heinemann K, Hartwig T, Witzigmann H, Lamesch P, Fangmann J, Berr F, Hauss J, Kohlhaw K.

Transplant Proc. 2001 Nov-Dec;33(7-8):3229-31. No abstract available.

PMID:
11750384
49.

Occupational exposure and liver cancer in women: results of the Multicentre International Liver Tumour Study (MILTS).

Heinemann K, Willich SN, Heinemann LA, DoMinh T, Möhner M, Heuchert GE.

Occup Med (Lond). 2000 Aug;50(6):422-9.

PMID:
10994245
50.

Current development of the human and environmental contamination in the Bryansk-Gomel Spot after the Chernobyl accident.

Hille R, Hill P, Heinemann K, Ramzaev V, Barkovski A, Konoplia V, Neth R.

Radiat Environ Biophys. 2000 Jun;39(2):99-109.

PMID:
10929378

Supplemental Content

Loading ...
Support Center